GO
Loading...

R&D For Your Portfolio: 3 Stocks in 3 Sectors

Wednesday, 17 Apr 2013 | 7:44 AM ET

Mark Lehmann, JMP Securities president, provides investment strategies that include a biotech company with a promising drug to fight a rare form of Leukemia.